Канада - Енглески - Health Canada

cheplapharm arzneimittel gmbh - omeprazole (omeprazole magnesium) - tablet (delayed-release) - 20mg - omeprazole (omeprazole magnesium) 20mg - proton-pump inhibitors

Канада - Енглески - Health Canada

cheplapharm arzneimittel gmbh - buserelin (buserelin acetate) - solution - 100mcg - buserelin (buserelin acetate) 100mcg - antineoplastic agents

Канада - Енглески - Health Canada

cheplapharm arzneimittel gmbh - buserelin (buserelin acetate) - solution - 1mg - buserelin (buserelin acetate) 1mg - antineoplastic agents

Канада - Енглески - Health Canada

cheplapharm arzneimittel gmbh - verteporfin - powder for solution - 15mg - verteporfin 15mg - eent drugs, miscellaneous

Канада - Енглески - Health Canada

cheplapharm arzneimittel gmbh - omeprazole (omeprazole magnesium) - tablet (delayed-release) - 10mg - omeprazole (omeprazole magnesium) 10mg - proton-pump inhibitors

Канада - Енглески - Health Canada

cheplapharm arzneimittel gmbh - omeprazole (omeprazole magnesium) - tablet (delayed-release) - 20mg - omeprazole (omeprazole magnesium) 20mg - proton-pump inhibitors

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

cheplapharm arzneimittel gmbh - carvedilol - tablet - 12.5 milligram(s) - alpha and beta blocking agents; carvedilol

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

cheplapharm arzneimittel gmbh - carvedilol - tablet - 25 milligram(s) - alpha and beta blocking agents; carvedilol

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

cheplapharm arzneimittel gmbh - carvedilol - tablet - 6.25 milligram(s) - alpha and beta blocking agents; carvedilol

Европска Унија - Енглески - EMA (European Medicines Agency)

cheplapharm arzneimittel gmbh - capecitabine - colonic neoplasms; breast neoplasms; colorectal neoplasms; stomach neoplasms - antineoplastic agents - xeloda is indicated for the adjuvant treatment of patients following surgery of stage iii (dukes' stage c) colon cancer.xeloda is indicated for the treatment of metastatic colorectal cancer.xeloda is indicated for first-line treatment of advanced gastric cancer in combination with a platinum-based regimen.xeloda in combination with docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy. previous therapy should have included an anthracycline. xeloda is also indicated as monotherapy for the treatment of patients with locally advanced or metastatic breast cancer after failure of taxanes and an anthracycline-containing chemotherapy regimen or for whom further anthracycline therapy is not indicated.